Angelalign Technology（AGLF.F）株式概要投資持株会社であるエンジェライン・テクノロジー社は、中華人民共和国および国際的なクリアアライナー治療ソリューションの研究、設計、製造、販売を行っています。 詳細AGLF.F ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長4/6過去の実績4/6財務の健全性6/6配当金3/6報酬収益は年間29.07%増加すると予測されています 過去1年間で収益は134.7%増加しました リスク分析株式の流動性は非常に低い 6.5%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見るAGLF.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW462,510 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA462,510 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$12.0026.8% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0770m2016201920222025202620282031Revenue US$769.6mEarnings US$59.1mAdvancedSet Fair ValueView all narrativesAngelalign Technology Inc. 競合他社Inspire Medical SystemsSymbol: NYSE:INSPMarket cap: US$1.8bLeMaitre VascularSymbol: NasdaqGM:LMATMarket cap: US$1.9bOmnicellSymbol: NasdaqGS:OMCLMarket cap: US$1.7bCONMEDSymbol: NYSE:CNMDMarket cap: US$1.5b価格と性能株価の高値、安値、推移の概要Angelalign Technology過去の株価現在の株価HK$12.0052週高値HK$12.2452週安値HK$8.17ベータ1.221ヶ月の変化15.38%3ヶ月変化n/a1年変化n/a3年間の変化n/a5年間の変化n/aIPOからの変化42.01%最新ニュースお知らせ • Aug 12Align Technology Prevails In China Patent Infringement Action Against AngelalignAlign Technology Inc. announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. The ruling remains subject to appeal. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.お知らせ • Aug 03+ 1 more updateAngelalign Technology Inc. to Report First Half, 2026 Results on Aug 31, 2026Angelalign Technology Inc. announced that they will report first half, 2026 results on Aug 31, 2026お知らせ • Jul 08Angelalign Technology Inc. Launches Iortho Release 6.2 With New CBCT Visualization, Trimline Flexibility, And Redesigned Prescription FormAngelalign Technology Inc. launched iOrtho Release 6.2 with new improvements in CBCT visualization, new trimline flexibility and a redesigned Rx form. The release puts real clinical advances directly in doctors' hands, from fuller CBCT visualization featuring new 3D diagnostic views, to multiple trimline options, to a redesigned Rx for Primary and Refinement cases, alongside a set of optimizations that sharpen the tools doctors rely on day to day. Release 6.2 reflects Angel Aligner's continued investment in giving orthodontists the tools to treat with confidence. New improvements in CBCT Visualization: IRS (Intelligent Root System) Gold provides detailed 3D visualizations of cortical and cancellous bone, maxillary sinus, and airway structures for more comprehensive case evaluation. Updated color mapping also makes it easier to distinguish tissue types at-a-glance, helping doctors evaluate anatomical structures more efficiently during case review. Variable Trimline in Rx: For the first time, three trimline options — Standard (scalloped), Full-Arch High, and High at Posterior Teeth Only — are built directly into the Rx form, giving doctors more control at the prescription stage, before setup even starts. There's flexibility after the fact too: doctors can downgrade their trimline selection directly in iOrtho at approval, and upgrade from Posterior Only to Full-Arch on their own. Redesigned Prescription Form for Primary and Refinement Cases: For both Primary and Refinement cases, the prescription form is being redesigned for all users to give doctors more clinical control right at the point of prescription. Building on existing Rx capabilities, the updated form expands what doctors can specify at the prescription stage, giving them more clinical control before setup even begins. Refreshed Treatment Plan Interface: The 3D user interface has been redesigned to make planning faster and more intuitive. The 3D modification tools (Tooth, Features, Arch, Occlusal Plane) now sit in the top-right of the 3D view, so doctors can access and switch between them more easily. This helps doctors evaluate treatment options more efficiently and with greater confidence. Additional Improvements From Doctor Feedback: Beyond the major features, Release 6.2 includes several smaller improvements that came directly from doctor feedback. Each update addresses a specific request raised by orthodontists using the platform. iOrtho Release 6.2 went live July 1.お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.最新情報をもっと見るRecent updatesお知らせ • Aug 12Align Technology Prevails In China Patent Infringement Action Against AngelalignAlign Technology Inc. announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. The ruling remains subject to appeal. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.お知らせ • Aug 03+ 1 more updateAngelalign Technology Inc. to Report First Half, 2026 Results on Aug 31, 2026Angelalign Technology Inc. announced that they will report first half, 2026 results on Aug 31, 2026お知らせ • Jul 08Angelalign Technology Inc. Launches Iortho Release 6.2 With New CBCT Visualization, Trimline Flexibility, And Redesigned Prescription FormAngelalign Technology Inc. launched iOrtho Release 6.2 with new improvements in CBCT visualization, new trimline flexibility and a redesigned Rx form. The release puts real clinical advances directly in doctors' hands, from fuller CBCT visualization featuring new 3D diagnostic views, to multiple trimline options, to a redesigned Rx for Primary and Refinement cases, alongside a set of optimizations that sharpen the tools doctors rely on day to day. Release 6.2 reflects Angel Aligner's continued investment in giving orthodontists the tools to treat with confidence. New improvements in CBCT Visualization: IRS (Intelligent Root System) Gold provides detailed 3D visualizations of cortical and cancellous bone, maxillary sinus, and airway structures for more comprehensive case evaluation. Updated color mapping also makes it easier to distinguish tissue types at-a-glance, helping doctors evaluate anatomical structures more efficiently during case review. Variable Trimline in Rx: For the first time, three trimline options — Standard (scalloped), Full-Arch High, and High at Posterior Teeth Only — are built directly into the Rx form, giving doctors more control at the prescription stage, before setup even starts. There's flexibility after the fact too: doctors can downgrade their trimline selection directly in iOrtho at approval, and upgrade from Posterior Only to Full-Arch on their own. Redesigned Prescription Form for Primary and Refinement Cases: For both Primary and Refinement cases, the prescription form is being redesigned for all users to give doctors more clinical control right at the point of prescription. Building on existing Rx capabilities, the updated form expands what doctors can specify at the prescription stage, giving them more clinical control before setup even begins. Refreshed Treatment Plan Interface: The 3D user interface has been redesigned to make planning faster and more intuitive. The 3D modification tools (Tooth, Features, Arch, Occlusal Plane) now sit in the top-right of the 3D view, so doctors can access and switch between them more easily. This helps doctors evaluate treatment options more efficiently and with greater confidence. Additional Improvements From Doctor Feedback: Beyond the major features, Release 6.2 includes several smaller improvements that came directly from doctor feedback. Each update addresses a specific request raised by orthodontists using the platform. iOrtho Release 6.2 went live July 1.お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026お知らせ • Feb 13Align Technology Inc. Announces Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on UsersAngelalign Technology Inc. said a ruling by the Unified Patent Court of Dusseldorf, Germany that it preliminarily cease its use of certain software functions that automatically update treatment plans would have minimal impact on the orthodontists and patients who use its clear aligner products. The ruling applies to certain European countries and excludes Spain, Switzerland, United Kingdom and Ireland. Angel will launch iPlan for applicable European users, which is an upgrade feature that has the same reliability and more flexibility for users. Angel denied that the Live Now feature in its iOrtho treatment planning software infringes any valid patents of Align Technology Inc. (ALGN). Angel has already filed an opposition against the patent with the European Patent Office (EPO), asserting that the claimed invention is neither novel nor inventive over the prior art, and is seeking its permanent invalidation. Angel is confident it will overcome the first- instance, non-final and preliminary injunction issued by the Dusseldorf court. For many years, Angel has focused on developing innovative solutions in the clear-aligner segment. Among its cutting-edge products are the award-winning angelButton, the angelHook, the A6 mandibular advancement system (now celebrating its ten-year anniversary), the angel KiD system, and the Intelligent Root System. The company is committed to bringing fair and healthy competition to the marketplace to benefit doctors and their patients.お知らせ • Sep 25Angelalign Technologies Remains Confident in Light of Its Competitor's New Complaint and Diversion TacticAngelalign Technology Inc. remained confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of lawsuits launched by Align. Angel promises an effective defense and is confident that it will prevail. The company has innovated and operated for over 20 years with a strong reputation and track record of respecting intellectual property. Angel serves doctors and patients in 60 countries and regularly receives industry-leading satisfaction ratings. Angel has proudly led the clear-aligner field in innovation for many years while also recognizing Align's founding role in creating the industry years ago. Some examples of Angel's cutting-edge products are: The angelButton™ and the angelHook™, which allow orthodontists to manage forces effectively when using elastics. The A6 mandibular advancement system, which implements the twin-block orthodontic concept for doctors to move the mandible. AngelKid, a leading system to treat mixed dentition for young patients. Intelligent Root System, which allows orthodontists to use 3D imaging for treatment planning.お知らせ • Aug 19Align Technology Initiates Patent Infringement Ligitation Against Angelalign TechnologyAlign Technology Inc. announced the filing of patent infringement lawsuits against Angelalign Technology Inc. (Angel). The lawsuits allege that Angel’s products and associated software infringe Align patents, which encompass innovations such as multilayer aligner materials, cutting-edge treatment planning, and advanced aligner features. These legal actions have been initiated in the United States, Europe and China, jurisdictions where Align has made significant investments in innovation, aligner fabrication and treatment planning. Align seeks both injunctive relief and monetary damages through these intellectual property enforcement efforts.お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2025 Results on Aug 25, 2025Angelalign Technology Inc. announced that they will report first half, 2025 results on Aug 25, 2025お知らせ • Mar 20Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2024, Payable on 20 June 2025Angelalign Technology Inc. proposed special final dividend of HKD 0.38 per share for the year ended 31 December 2024. Date of shareholders' approval is 23 May 2025. Ex-dividend date is 27 May 2025. Record date is 2 June 2025. Payment date is 20 June 2025.お知らせ • Mar 05Angelalign Technology Inc. to Report Fiscal Year 2024 Results on Mar 20, 2025Angelalign Technology Inc. announced that they will report fiscal year 2024 results on Mar 20, 2025お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2024 Results on Aug 22, 2024Angelalign Technology Inc. announced that they will report first half, 2024 results on Aug 22, 2024お知らせ • Jun 28Angelalign Technology Inc. Approves the Special Dividend for the Year Ended December 31, 2023Angelalign Technology Inc. announced that at its AGM held on June 28, 2024, approved the special dividend of HKD 1.1 per share of the Company for the year ended December 31, 2023.お知らせ • May 01Angel Aligner Accelerates Expansion with Enhanced Features and a Canadian LaunchAngelalign Technology Inc. announced new doctor driven features along with expansion into the Canadian market. The new features and expansion culminate the company's first year serving Orthodontists in North America. Doctor-driven innovations include: The enhanced iOrtho Workbench featuring an intuitive interface and 3D controls that makes the powerful and secure iOrtho cloud-based treatment planning software even easier and more predictable to use. The launch of a flexible template that provides team members with an alternative option to easily place attachments. StarSort feature that allows orthodontists to color code and easily filter patients, simplifying the tracking of treatment stages, prioritization of next steps, and creation of custom groups. A new attachment height tool that allows Orthodontists to adjust the vertical height of attachments during the treatment planning process. The Angel team welcomes the opportunity to meet orthodontic professionals and demonstrate the new innovations of Angel Aligners in person at booth # 3145 at the American Association of Orthodontists (AAO) Annual Session in New Orleans, May 3–5, 2024.お知らせ • Apr 20Angelalign Technology Inc. Launches in Canada with Innovative Aligner Technology Built on 20+ Years of Experience and 1+ Million SmilesAngelalign Technology Inc. announced the launch of Angel Aligner in Canada. Orthodontists in Canada now have access to Angel Aligner's leading-edge technology built on the company's 20+ years of experience, commitment to research and digital innovation. Angelalign Technology collaborates with orthodontists around the world to innovate aligner technology that addresses complex orthodontic movements. Angel Aligner introduces Canadian practices to a wide range of innovations that support orthodontists in transforming their patients' smiles with increased efficiency, simplicity and flexibility. These innovations unique to Angel Aligner include: iOrtho™ secure cloud service platform featuring intuitive treatment planning software with 3D controls for enhanced customization and review of case designs. angelButton™ an auxiliary anchorage button integrated directly into the aligner, designed to provide greater flexibility with positioning and reduce chair-side time required for button bonding. Intelligent Ceph System (ICS) with automatic recognition of anatomical landmarks, contours, and auxiliary points.お知らせ • Mar 21Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024Angelalign Technology Inc. proposed special final dividend of HKD 1.1 per share for the year ended 31 December 2023. Ex-dividend date is 27 May 2024. Record date is 31 May 2024. Payment date is 24 June 2024. Date of shareholders' approval is 23 May 2024.お知らせ • Mar 20Angelalign Technology Inc., Annual General Meeting, May 23, 2024Angelalign Technology Inc., Annual General Meeting, May 23, 2024.お知らせ • Mar 08Angelalign Technology Inc. to Report Fiscal Year 2023 Results on Mar 19, 2024Angelalign Technology Inc. announced that they will report fiscal year 2023 results on Mar 19, 2024株主還元AGLF.FUS Medical EquipmentUS 市場7D-2.0%-1.2%-2.1%1Yn/a-12.8%18.8%株主還元を見る業界別リターン: AGLF.FがUS Medical Equipment業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: AGLF.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is AGLF.F's price volatile compared to industry and market?AGLF.F volatilityAGLF.F Average Weekly Movementn/aMedical Equipment Industry Average Movement8.4%Market Average Movement7.2%10% most volatile stocks in US Market16.3%10% least volatile stocks in US Market3.1%安定した株価: AGLF.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のAGLF.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト20034,312Fox Huwww.angelalign.com投資持株会社であるAngelalign Technology Inc.は、中華人民共和国および国際的なクリアアライナー治療ソリューションの研究、設計、製造、販売を行っています。同社の製品には、時間をかけて患者の歯を適切な位置に移動させる、カスタムメイドの取り外し可能な透明矯正アライナー「エンジェルアライナー・プロ」などがある。また、歯科クリニックを通じて矯正歯科や審美歯科、その他の歯科サービスを提供するほか、口腔内スキャナーの販売も行っている。エンジェライン・テクノロジー社は2003年に設立され、中国の上海に本社を置いている。アンジェライン・テクノロジー社はケアキャピタル・オーソテック社の子会社である。もっと見るAngelalign Technology Inc. 基礎のまとめAngelalign Technology の収益と売上を時価総額と比較するとどうか。AGLF.F 基礎統計学時価総額US$1.98b収益（TTM）US$28.44m売上高(TTM)US$370.28m69.7xPER（株価収益率5.4xP/SレシオAGLF.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AGLF.F 損益計算書（TTM）収益US$370.28m売上原価US$137.39m売上総利益US$232.89mその他の費用US$204.45m収益US$28.44m直近の収益報告Dec 31, 2025次回決算日Aug 31, 2026一株当たり利益（EPS）0.17グロス・マージン62.90%純利益率7.68%有利子負債／自己資本比率0.5%AGLF.F の長期的なパフォーマンスは？過去の実績と比較を見る配当金6.5%現在の配当利回り37%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 06:21終値2026/08/17 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Angelalign Technology Inc. 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Bo LiBofA Global ResearchYanyin ZhuChina International Capital Corporation LimitedMujun ShenCitic Securities Co., Ltd.8 その他のアナリストを表示
お知らせ • Aug 12Align Technology Prevails In China Patent Infringement Action Against AngelalignAlign Technology Inc. announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. The ruling remains subject to appeal. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.
お知らせ • Aug 03+ 1 more updateAngelalign Technology Inc. to Report First Half, 2026 Results on Aug 31, 2026Angelalign Technology Inc. announced that they will report first half, 2026 results on Aug 31, 2026
お知らせ • Jul 08Angelalign Technology Inc. Launches Iortho Release 6.2 With New CBCT Visualization, Trimline Flexibility, And Redesigned Prescription FormAngelalign Technology Inc. launched iOrtho Release 6.2 with new improvements in CBCT visualization, new trimline flexibility and a redesigned Rx form. The release puts real clinical advances directly in doctors' hands, from fuller CBCT visualization featuring new 3D diagnostic views, to multiple trimline options, to a redesigned Rx for Primary and Refinement cases, alongside a set of optimizations that sharpen the tools doctors rely on day to day. Release 6.2 reflects Angel Aligner's continued investment in giving orthodontists the tools to treat with confidence. New improvements in CBCT Visualization: IRS (Intelligent Root System) Gold provides detailed 3D visualizations of cortical and cancellous bone, maxillary sinus, and airway structures for more comprehensive case evaluation. Updated color mapping also makes it easier to distinguish tissue types at-a-glance, helping doctors evaluate anatomical structures more efficiently during case review. Variable Trimline in Rx: For the first time, three trimline options — Standard (scalloped), Full-Arch High, and High at Posterior Teeth Only — are built directly into the Rx form, giving doctors more control at the prescription stage, before setup even starts. There's flexibility after the fact too: doctors can downgrade their trimline selection directly in iOrtho at approval, and upgrade from Posterior Only to Full-Arch on their own. Redesigned Prescription Form for Primary and Refinement Cases: For both Primary and Refinement cases, the prescription form is being redesigned for all users to give doctors more clinical control right at the point of prescription. Building on existing Rx capabilities, the updated form expands what doctors can specify at the prescription stage, giving them more clinical control before setup even begins. Refreshed Treatment Plan Interface: The 3D user interface has been redesigned to make planning faster and more intuitive. The 3D modification tools (Tooth, Features, Arch, Occlusal Plane) now sit in the top-right of the 3D view, so doctors can access and switch between them more easily. This helps doctors evaluate treatment options more efficiently and with greater confidence. Additional Improvements From Doctor Feedback: Beyond the major features, Release 6.2 includes several smaller improvements that came directly from doctor feedback. Each update addresses a specific request raised by orthodontists using the platform. iOrtho Release 6.2 went live July 1.
お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.
お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.
お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.
お知らせ • Aug 12Align Technology Prevails In China Patent Infringement Action Against AngelalignAlign Technology Inc. announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. The ruling remains subject to appeal. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.
お知らせ • Aug 03+ 1 more updateAngelalign Technology Inc. to Report First Half, 2026 Results on Aug 31, 2026Angelalign Technology Inc. announced that they will report first half, 2026 results on Aug 31, 2026
お知らせ • Jul 08Angelalign Technology Inc. Launches Iortho Release 6.2 With New CBCT Visualization, Trimline Flexibility, And Redesigned Prescription FormAngelalign Technology Inc. launched iOrtho Release 6.2 with new improvements in CBCT visualization, new trimline flexibility and a redesigned Rx form. The release puts real clinical advances directly in doctors' hands, from fuller CBCT visualization featuring new 3D diagnostic views, to multiple trimline options, to a redesigned Rx for Primary and Refinement cases, alongside a set of optimizations that sharpen the tools doctors rely on day to day. Release 6.2 reflects Angel Aligner's continued investment in giving orthodontists the tools to treat with confidence. New improvements in CBCT Visualization: IRS (Intelligent Root System) Gold provides detailed 3D visualizations of cortical and cancellous bone, maxillary sinus, and airway structures for more comprehensive case evaluation. Updated color mapping also makes it easier to distinguish tissue types at-a-glance, helping doctors evaluate anatomical structures more efficiently during case review. Variable Trimline in Rx: For the first time, three trimline options — Standard (scalloped), Full-Arch High, and High at Posterior Teeth Only — are built directly into the Rx form, giving doctors more control at the prescription stage, before setup even starts. There's flexibility after the fact too: doctors can downgrade their trimline selection directly in iOrtho at approval, and upgrade from Posterior Only to Full-Arch on their own. Redesigned Prescription Form for Primary and Refinement Cases: For both Primary and Refinement cases, the prescription form is being redesigned for all users to give doctors more clinical control right at the point of prescription. Building on existing Rx capabilities, the updated form expands what doctors can specify at the prescription stage, giving them more clinical control before setup even begins. Refreshed Treatment Plan Interface: The 3D user interface has been redesigned to make planning faster and more intuitive. The 3D modification tools (Tooth, Features, Arch, Occlusal Plane) now sit in the top-right of the 3D view, so doctors can access and switch between them more easily. This helps doctors evaluate treatment options more efficiently and with greater confidence. Additional Improvements From Doctor Feedback: Beyond the major features, Release 6.2 includes several smaller improvements that came directly from doctor feedback. Each update addresses a specific request raised by orthodontists using the platform. iOrtho Release 6.2 went live July 1.
お知らせ • May 14Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement ClaimAngelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded.
お知らせ • Mar 29Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026.
お知らせ • Mar 28+ 1 more updateAngelalign Technology Inc. announces Annual dividend, payable on June 08, 2026Angelalign Technology Inc. announced Annual dividend of HKD 0.4800 per share payable on June 08, 2026, ex-date on May 21, 2026 and record date on May 22, 2026.
お知らせ • Feb 25Angelalign Technology Inc. to Report Fiscal Year 2025 Results on Mar 27, 2026Angelalign Technology Inc. announced that they will report fiscal year 2025 results on Mar 27, 2026
お知らせ • Feb 13Align Technology Inc. Announces Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on UsersAngelalign Technology Inc. said a ruling by the Unified Patent Court of Dusseldorf, Germany that it preliminarily cease its use of certain software functions that automatically update treatment plans would have minimal impact on the orthodontists and patients who use its clear aligner products. The ruling applies to certain European countries and excludes Spain, Switzerland, United Kingdom and Ireland. Angel will launch iPlan for applicable European users, which is an upgrade feature that has the same reliability and more flexibility for users. Angel denied that the Live Now feature in its iOrtho treatment planning software infringes any valid patents of Align Technology Inc. (ALGN). Angel has already filed an opposition against the patent with the European Patent Office (EPO), asserting that the claimed invention is neither novel nor inventive over the prior art, and is seeking its permanent invalidation. Angel is confident it will overcome the first- instance, non-final and preliminary injunction issued by the Dusseldorf court. For many years, Angel has focused on developing innovative solutions in the clear-aligner segment. Among its cutting-edge products are the award-winning angelButton, the angelHook, the A6 mandibular advancement system (now celebrating its ten-year anniversary), the angel KiD system, and the Intelligent Root System. The company is committed to bringing fair and healthy competition to the marketplace to benefit doctors and their patients.
お知らせ • Sep 25Angelalign Technologies Remains Confident in Light of Its Competitor's New Complaint and Diversion TacticAngelalign Technology Inc. remained confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of lawsuits launched by Align. Angel promises an effective defense and is confident that it will prevail. The company has innovated and operated for over 20 years with a strong reputation and track record of respecting intellectual property. Angel serves doctors and patients in 60 countries and regularly receives industry-leading satisfaction ratings. Angel has proudly led the clear-aligner field in innovation for many years while also recognizing Align's founding role in creating the industry years ago. Some examples of Angel's cutting-edge products are: The angelButton™ and the angelHook™, which allow orthodontists to manage forces effectively when using elastics. The A6 mandibular advancement system, which implements the twin-block orthodontic concept for doctors to move the mandible. AngelKid, a leading system to treat mixed dentition for young patients. Intelligent Root System, which allows orthodontists to use 3D imaging for treatment planning.
お知らせ • Aug 19Align Technology Initiates Patent Infringement Ligitation Against Angelalign TechnologyAlign Technology Inc. announced the filing of patent infringement lawsuits against Angelalign Technology Inc. (Angel). The lawsuits allege that Angel’s products and associated software infringe Align patents, which encompass innovations such as multilayer aligner materials, cutting-edge treatment planning, and advanced aligner features. These legal actions have been initiated in the United States, Europe and China, jurisdictions where Align has made significant investments in innovation, aligner fabrication and treatment planning. Align seeks both injunctive relief and monetary damages through these intellectual property enforcement efforts.
お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2025 Results on Aug 25, 2025Angelalign Technology Inc. announced that they will report first half, 2025 results on Aug 25, 2025
お知らせ • Mar 20Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2024, Payable on 20 June 2025Angelalign Technology Inc. proposed special final dividend of HKD 0.38 per share for the year ended 31 December 2024. Date of shareholders' approval is 23 May 2025. Ex-dividend date is 27 May 2025. Record date is 2 June 2025. Payment date is 20 June 2025.
お知らせ • Mar 05Angelalign Technology Inc. to Report Fiscal Year 2024 Results on Mar 20, 2025Angelalign Technology Inc. announced that they will report fiscal year 2024 results on Mar 20, 2025
お知らせ • Aug 09Angelalign Technology Inc. to Report First Half, 2024 Results on Aug 22, 2024Angelalign Technology Inc. announced that they will report first half, 2024 results on Aug 22, 2024
お知らせ • Jun 28Angelalign Technology Inc. Approves the Special Dividend for the Year Ended December 31, 2023Angelalign Technology Inc. announced that at its AGM held on June 28, 2024, approved the special dividend of HKD 1.1 per share of the Company for the year ended December 31, 2023.
お知らせ • May 01Angel Aligner Accelerates Expansion with Enhanced Features and a Canadian LaunchAngelalign Technology Inc. announced new doctor driven features along with expansion into the Canadian market. The new features and expansion culminate the company's first year serving Orthodontists in North America. Doctor-driven innovations include: The enhanced iOrtho Workbench featuring an intuitive interface and 3D controls that makes the powerful and secure iOrtho cloud-based treatment planning software even easier and more predictable to use. The launch of a flexible template that provides team members with an alternative option to easily place attachments. StarSort feature that allows orthodontists to color code and easily filter patients, simplifying the tracking of treatment stages, prioritization of next steps, and creation of custom groups. A new attachment height tool that allows Orthodontists to adjust the vertical height of attachments during the treatment planning process. The Angel team welcomes the opportunity to meet orthodontic professionals and demonstrate the new innovations of Angel Aligners in person at booth # 3145 at the American Association of Orthodontists (AAO) Annual Session in New Orleans, May 3–5, 2024.
お知らせ • Apr 20Angelalign Technology Inc. Launches in Canada with Innovative Aligner Technology Built on 20+ Years of Experience and 1+ Million SmilesAngelalign Technology Inc. announced the launch of Angel Aligner in Canada. Orthodontists in Canada now have access to Angel Aligner's leading-edge technology built on the company's 20+ years of experience, commitment to research and digital innovation. Angelalign Technology collaborates with orthodontists around the world to innovate aligner technology that addresses complex orthodontic movements. Angel Aligner introduces Canadian practices to a wide range of innovations that support orthodontists in transforming their patients' smiles with increased efficiency, simplicity and flexibility. These innovations unique to Angel Aligner include: iOrtho™ secure cloud service platform featuring intuitive treatment planning software with 3D controls for enhanced customization and review of case designs. angelButton™ an auxiliary anchorage button integrated directly into the aligner, designed to provide greater flexibility with positioning and reduce chair-side time required for button bonding. Intelligent Ceph System (ICS) with automatic recognition of anatomical landmarks, contours, and auxiliary points.
お知らせ • Mar 21Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024Angelalign Technology Inc. proposed special final dividend of HKD 1.1 per share for the year ended 31 December 2023. Ex-dividend date is 27 May 2024. Record date is 31 May 2024. Payment date is 24 June 2024. Date of shareholders' approval is 23 May 2024.
お知らせ • Mar 20Angelalign Technology Inc., Annual General Meeting, May 23, 2024Angelalign Technology Inc., Annual General Meeting, May 23, 2024.
お知らせ • Mar 08Angelalign Technology Inc. to Report Fiscal Year 2023 Results on Mar 19, 2024Angelalign Technology Inc. announced that they will report fiscal year 2023 results on Mar 19, 2024
